Sagimet Biosciences (SGMT) Change in Accured Expenses (2023 - 2024)
Historic Change in Accured Expenses for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to -$1.7 million.
- Sagimet Biosciences' Change in Accured Expenses fell 21951.04% to -$1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$1.0 million, marking a year-over-year change of. This contributed to the annual value of -$907000.0 for FY2024, which is 85583.33% down from last year.
- Per Sagimet Biosciences' latest filing, its Change in Accured Expenses stood at -$1.7 million for Q3 2024, which was down 21951.04% from $1.1 million recorded in Q2 2024.
- Over the past 5 years, Sagimet Biosciences' Change in Accured Expenses peaked at $1.4 million during Q3 2023, and registered a low of -$1.7 million during Q3 2024.